Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin in older adults with type 2 diabetes mellitus

Journal of the American Geriatrics Society

Volumn 59, Issue 6, 2011, Pages 1148-1149

  Stafford, Sara ^a   Elahi, Dariush ^b   Meneilly, Graydon S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; SITAGLIPTIN;

ABSENCE OF SIDE EFFECTS; AGED; AREA UNDER THE CURVE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LETTER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL;

AGE FACTORS; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; MALE; PYRAZINES; TREATMENT OUTCOME; TRIAZOLES;

EID: 79958844539     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03438.x     Document Type: Letter

References (9)

1. Meneilly GS, Tessier D., Diabetes in elderly adults. J Gerontol A Biol Sci Med Sci 2001; 56A: M5-M13. (Pubitemid 32042962)
2. Nauck MA., Unraveling the science of incretin biology. Am J Med 2009; 122: S3-S10.
3. Gilbert MP, Pratley RE., Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus. Am J Med 2009; 122: S11-S24.
4. Andres R, Swerdloff R, Pozefsky T, et al,. Manual feedback technique for control of glucose concentration. In:, Skeggs LT Jr., ed. Automation in Analytic Chemistry. New York: Mediad Inc; 1996, pp 486-501.
5. Meneilly GS, Greig N, Tildesley H, et al,. Effects of 3 months of continuous subcutaneous administration of glucagon-like peptide 1 in elderly patients with type 2 diabetes. Diabetes Care 2003; 26: 2835-2841. (Pubitemid 37205555)
6. Elahi D, McAloon-Dyke M, Fukagawa NK, et al,. The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagons-like peptide-1(7-37) in normal and diabetic subjects. Regul Pept 1994; 51: 63-74. (Pubitemid 24119981)
7. Korosi J, McIntosh CHS, Pederson RA, et al,. Effect of aging and diabetes on the enteroinsular axis. J Gerontol A Biol Sci Med Sci 2001; 56A: M1-M5.
8. Meneilly GS, Demuth HU, McIntosh CHS, et al,. Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose. Diabetic Med 2000; 17: 346-350. (Pubitemid 30353798)
9. Meneilly GS, McIntosh CHS, Pederson RA, et al,. GLP-1 augments insulin release in elderly patients with diabetes. Diabetes Care 2001; 24: 965.